Characterisation of digital therapeutic clinical trials: a systematic review with natural language processing
Year: 2024
Type: review
Study design: Systematic Review
Abstract: Digital therapeutics (DTx) are a somewhat novel class of US Food and Drug Administration-regulated software that help patients prevent, manage, or treat disease. Here, we use natural language processing to characterise registered DTx clinical trials and provide insights into the clinical development landscape for these novel therapeutics. We identified 449 DTx clinical trials, initiated or expected to be initiated between 2010 and 2030, from ClinicalTrials.gov using 27 search terms, and available data were analysed, including trial durations, locations, MeSH categories, enrolment, and sponsor types. Topic modelling of eligibility criteria, done with BERTopic, showed that DTx trials frequently exclude patients on the basis of age, comorbidities, pregnancy, language barriers, and digital determinants of health, including smartphone or data plan access. Our comprehensive overview of the DTx development landscape highlights challenges in designing inclusive DTx clinical trials and presents opportunities for clinicians and researchers to address these challenges. Finally, we provide an interactive dashboard for readers to conduct their own analyses.
Source: The Lancet Digital Health
Language: English
Subfield: Applied Psychology
Field: Psychology
Domain: Social Sciences
Open Access status: gold
Estimated APC paid: $5,780
Funders: California Institute for Regenerative Medicine, March of Dimes Foundation, Alnylam Pharmaceuticals, Stryker, Leon Lowenstein Foundation, National Institutes of Health, U.S. Food and Drug Administration, Genentech, University of California, San Francisco, Center of Excellence in Regulatory Science and Innovation, Clinical and Translational Science Institute, Boston University, National Institute of General Medical Sciences, U.S. National Library of Medicine, National Center for Advancing Translational Sciences
OpenAlex ID: W4392017198
